Target intelligence / Profile preview

Lolium perenne pollen allergen Lol p 5 (Lol p 5)

Target
Lol p 5
Molecular classification
Allergen, Group 5 grass pollen allergen
01

Overview

Lolium perenne pollen allergen Lol p 5 is a major protein allergen derived from perennial ryegrass, a primary source of seasonal aeroallergens globally (UniProt Q40240). It belongs to the Group 5 grass pollen allergens, which are characterized by their high solubility and potency in inducing IgE-mediated Type I hypersensitivity (IUIS Allergen Nomenclature). Lol p 5 is localized within the starch granules of pollen and is released upon contact with mucosal surfaces. Once released, it cross-links IgE on mast cells and basophils, triggering the release of inflammatory mediators like histamine (PubMed: 8230054). In clinical practice, Lol p 5 is a critical component of diagnostic tests and allergen-specific immunotherapy (AIT) products. Therapeutic strategies involving Lol p 5 include the use of standardized grass pollen extracts to desensitize patients. The therapeutic goal of targeting Lol p 5 via AIT is to shift the immune system from a Th2-dominated allergic response to a Th1/Treg-mediated tolerant state (PubMed: 25173434). This modulation leads to a reduction in symptoms of allergic rhinitis and asthma. Monitoring of therapy often involves measuring changes in allergen-specific IgE and IgG4 levels. Safety remains a concern during treatment due to the risk of systemic allergic reactions or anaphylaxis.

Other names
Lol p VMajor pollen allergen Lol p 5Ryegrass allergen 5
02

Mechanism of action

Induction of immune tolerance through allergen-specific immunotherapy (AIT)

03

Biological functions

Immune responsePollen development
04

Disease associations

Allergic rhinitisAllergic asthmaType I hypersensitivity
05

Safety considerations

AnaphylaxisSystemic allergic reactionLocal site reaction
06

Interacting drugs

Grass pollen allergen extract

1 more in the full profile.

07

Biomarkers

Allergen-specific IgEAllergen-specific IgG4Skin prick test reactivity

Beyond the preview

Go deeper on Lolium perenne pollen allergen Lol p 5 (Lol p 5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lolium perenne pollen allergen Lol p 5 (Lol p 5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call